These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6962613)

  • 1. Amidolytic heparin assay (Coatest heparin) and correlation to clinical effects in heparin treatment of deep venous thrombosis (DVT).
    Holm HA
    Acta Chir Scand Suppl; 1982; 509():115-6. PubMed ID: 6962613
    [No Abstract]   [Full Text] [Related]  

  • 2. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
    Brewer D
    J Fam Pract; 1998 Sep; 47(3):185-92. PubMed ID: 9752370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antithrombotic effect of heparin in deep venous thrombosis: relation to four heparin assays.
    Holm HA; Abildgaard U; Kalvenes S; Anderssen N; Anker E; Arnesen KE; Blikom D; Drivenes A
    Acta Med Scand; 1984; 216(3):287-93. PubMed ID: 6496186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of deep venous thrombosis].
    Bounameaux H
    Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.
    Prandoni P; Villalta S; Bagatella P; Rossi L; Marchiori A; Piccioli A; Bernardi E; Girolami B; Simioni P; Girolami A
    Haematologica; 1997; 82(4):423-8. PubMed ID: 9299855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring heparin therapy--a role for the chromogenic assay.
    Chong LL; Sussman II; Spaet TH
    Clin Lab Haematol; 1983; 5(1):61-5. PubMed ID: 6851437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium.
    Berkowitz SD
    Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Round table on the treatment of deep venous thrombosis. Progress in the treatment using heparin].
    Breddin K
    Phlebologie; 1990; 43(4):667-70; discussion 670-1. PubMed ID: 2093923
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis.
    Thomas DP; Merton RE; Barrowcliffe TW; Thunberg L; Lindahl U
    Thromb Haemost; 1982 Jun; 47(3):244-8. PubMed ID: 7112499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving use of heparin in acute deep venous thrombosis.
    Gold JA; Ferguson CJ; Williams NF; Braun SK
    Wis Med J; 1996 May; 95(5):311-2. PubMed ID: 8936037
    [No Abstract]   [Full Text] [Related]  

  • 12. Markers of hemostatic system activation in acute deep venous thrombosis-evolution during the first days of heparin treatment. The DVTENOX Study Group.
    Thromb Haemost; 1993 Dec; 70(6):909-14. PubMed ID: 8165610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent heparin resistance form elevated factor VIII in a patient with postoperative deep venous thrombosis. A case report.
    Cirisano FD; Lee S; Greenspoon JS
    J Reprod Med; 1996 Mar; 41(3):191-4. PubMed ID: 8778420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts of anticoagulation therapy.
    Hull RD; Pineo GF
    Clin Chest Med; 1995 Jun; 16(2):269-80. PubMed ID: 7656539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low molecular weight heparin versus unfractionated heparin in the treatment of deep venous thrombosis--a meta-analysis].
    Nielsen JD; Landorph A
    Ugeskr Laeger; 1994 Oct; 156(40):5844-9. PubMed ID: 7985276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current aspects of the treatment of deep venous thromboses by heparin (author's transl)].
    Juillet Y; Morin D; Richard A; Fiessinger JN; Aiach M; Housset E
    Nouv Presse Med; 1980 Apr; 9(19):1349-52. PubMed ID: 7383849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation by constant subcutaneous heparin infusion.
    Parrilla N; Ansell J
    Thromb Haemost; 1982 Feb; 47(1):1-2. PubMed ID: 7071800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep venous thrombosis following immobilization after retinal detachment surgery.
    Chu TG; Pince KJ
    Ophthalmic Surg; 1993 Sep; 24(9):598-9. PubMed ID: 8233332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin treatment of deep vein thrombosis. Effects and complications after continuous or intermittent heparin administration.
    Fagher B; Lundh B
    Acta Med Scand; 1981; 210(5):357-61. PubMed ID: 7039244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.